FDA Requests Public Comment on Proposed Rule for Prescription Drug Labeling and Medication Guide Requirements

Summary

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (PRA). The FDA is seeking public comment on a proposed rule related to prescription drug product labeling and medication guide requirements.